ECOD
F-group (family)

2003.1.5.9 NNMT_PNMT_TEMT

Open in classification tree →Pfam PF01234 →

Ligands and drugs

203
Member domains
170
with ligand contacts (≤ 4 Å)
83.7% of members
167
with DrugDomain annotations
82.3% of members
133
with a DrugBank compound
65.5% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 2003.1.5.9 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB01752SAHS-adenosyl-L-homocysteine119
DB00118SAMAdemetionine4
DB02701NCANicotinamide4
DB07739F21(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE4
DB07747F83(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE4
DB117108GCTrigonellamide4
DB08631TMJN-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE3
DB00173ADEAdenine2
DB00368LNRNorepinephrine2
DB03468SKF1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide2
DB037291722-Amino-1H-benzimidazol-5-ol2
DB03824IDI7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline2
DB04273LY18,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine2
DB07597CTLCIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL2
DB07798FTS(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE2
DB07906HNT[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL2
DB08128LT3(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine2
DB08129LT5(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol2
DB08550SKA7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline2
DB08654TTLTRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL2

Most frequently bound compounds

PDB ligandNameDomains in contact
SAHS-ADENOSYL-L-HOMOCYSTEINE119
5R43-[3-(acetyl{[(1R,2R,3S,4R)-4-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,3-dihydroxycyclopentyl]methyl}amino)prop-1-yn-1-yl]benzamide6
8WO6-methoxy-1-methyl-2H-pyridine-3-carboxamide6
OTR4-(2R-AMINO-1-HYDROXYETHYL)PHENOL6
8GC3-carbamoyl-1-methylpyridin-1-ium4
9XL(2S)-2-amino-4-([3-(3-carbamoylphenyl)prop-2-yn-1-yl]{[(1R,2R,3S,4R)-4-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,3-dihydroxycyclopentyl]methyl}amino)butanoic acid4
F0P(2~{S})-5-[2-(3-aminocarbonylphenyl)ethyl-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]amino]-2-azanyl-pentanoic acid4
F21(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE4
F83(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE4
JCU10-methyl-1,10-diazatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-trien-11-imine4
JDL6-fluoranyl-10-methyl-1,10-diazatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-trien-11-imine4
N379-{9-amino-6-[(3-carbamoylphenyl)ethynyl]-5,6,7,8,9-pentadeoxy-D-glycero-alpha-L-talo-decofuranuronosyl}-9H-purin-6-amine4
NCANICOTINAMIDE4
OZP9-(5-{[(3S)-3-amino-3-carboxypropyl][3-(3-carbamoylphenyl)propyl]amino}-5-deoxy-alpha-D-ribofuranosyl)-9H-purin-6-amine4
P0V9-(5-{[(3R)-3-amino-3-carboxypropyl][3-(3-carbamoylphenyl)prop-2-yn-1-yl]amino}-5-deoxy-alpha-D-lyxofuranosyl)-9H-purin-6-amine4
SAMS-ADENOSYLMETHIONINE4
U0Z5,6-dihydro-2-imino-2H,4H-thiazolo(5,4,3-IJ)quinoline4
U1W3-ethyl-1,3-diazatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-trien-2-imine4
U722-methyl-1,2,6,7-tetrahydro-3H,5H-pyrido[3,2,1-ij]quinazolin-3-imine4
U7H2-hydroxy-1-(4-(isoquinolin-5-yl)piperazin-1-yl)-2-methyl-3-(3-methyl-4-phenyl-1H-pyrazol-1-yl)propan-1-one4